Lincoln Pharma reports best-ever results in a Financial Year; reports highest revenue, EBIDTA, Net Profit in FY22
Company reported net profit of Rs 69.36 crore for FY22 as against net profit of Rs 62.25 crore in the corresponding period last year, growth of 11.42 per cent.
United States Lincoln Pharma Mahendra Patel Lincoln Pharmaceuticals Department Of Scientific Therapeutic Goods Administration
Source: singaporestar.com